ARID2, CYSTM1, DDIT3, and RNASE1 expressions were changed in the peripheral blood mononuclear cells of the SLE sample, highly suggested for being used as the potential biomarkers with SLE to further research. This evidence concerns the gene CYSTM1 and systemic lupus erythematosus.